Irska - angleščina - HPRA (Health Products Regulatory Authority)

orion pharma a/s - tinidazole - tablets - 150 milligram

Irska - angleščina - HPRA (Health Products Regulatory Authority)

orion pharma a/s - tinidazole - tablets - 500 milligram

Irska - angleščina - HPRA (Health Products Regulatory Authority)

electramed ireland limited - tinidazole - 5 milligram

Evropska unija - angleščina - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - diphtheria toxoid, hepatitis b surface antigen, bordetella pertussis (inactivated), tetanus toxoid - hepatitis b; tetanus; immunization; whooping cough; diphtheria - vaccines - tritanrix hepb is indicated for active immunisation against diphtheria, tetanus, pertussis and hepatitis b (hbv) in infants from six weeks onwards (see section 4.2).

Izrael - angleščina - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - fluconazole - capsules - fluconazole 200 mg - fluconazole - fluconazole - fluconazole is indicated in the following fungal infections.fluconazole is indicated in adults for the treatment of:• cryptococcal meningitis.• coccidioidomycosis.• invasive candidiasis.• mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis.• chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.• vaginal candidiasis, acute or recurrent; when local therapy is not appropriate.• candidal balanitis when local therapy is not appropriate.• dermatomycosis including tinea pedis, tinea corporis, tinea cruris, tinea versicolor and dermal candida infections when systemic therapy is indicated.• tinea unguinium (onychomycosis) when other agents are not considered appropriate.fluconazole is indicated in adults for the prophylaxis of:• relapse of cryptococcal meningitis in patients with high risk of recurrence.• relapse of oropharyngeal or oesophageal candidiasis in patients infected with hiv who are at high risk of experiencing relapse.• to reduce the incidence of recurrent vaginal candidiasis (4 or more episodes a year).• prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving hematopoietic stem cell transplantation).fluconazole is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old:fluconazole is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. fluconazole can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence. therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti infective therapy should be adjusted accordingly.consideration should be given to official guidance on the appropriate use of antifungals.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - bordetella pertussis, inactivated 4 iu/ml; diphtheria toxoid, adsorbed 60 iu/ml; hepatitis b vaccine, rdna 20 µg/ml; tetanus toxoid 120 iu/ml; haemophilus influenzae vaccine, tetanus toxoid conjugate 20 µg/ml - suspension for injection - active: bordetella pertussis, inactivated 4 iu/ml diphtheria toxoid, adsorbed 60 iu/ml hepatitis b vaccine, rdna 20 µg/ml tetanus toxoid 120 iu/ml excipient: aluminium as aluminium phosphate and aluminium hydroxide. phenoxyethanol sodium chloride thiomersal water for injection active: haemophilus influenzae vaccine, tetanus toxoid conjugate 20 µg/ml excipient: lactose monohydrate sodium chloride

Egipt - angleščina - EDA (Egyptian Drug Authority)

smithkline beecham biologicals-belgium - injection

Filipini - angleščina - FDA (Food And Drug Administration)

pharmakon biotec, inc.; distributor: ranixx pharamaceuticals - ceftriaxone (as sodium) - powder for injection (im/iv) - 1 g

Bangladeš - angleščina - DGDA (Directorate General of Drug Administration)

beacon pharmaceuticals plc - brigatinib - tablet - 30 mg

Bangladeš - angleščina - DGDA (Directorate General of Drug Administration)

beacon pharmaceuticals plc - brigatinib - tablet - 90 mg